These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 23683126)

  • 1. Treatment with the sphingosine-1-phosphate analogue FTY 720 reduces loss of plasma volume during experimental sepsis in the rat.
    Lundblad C; Axelberg H; Grände PO
    Acta Anaesthesiol Scand; 2013 Jul; 57(6):713-8. PubMed ID: 23683126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FTY720 mitigates torsion/detorsion-induced testicular injury in rats.
    Shih HJ; Yen JC; Chiu AW; Chow YC; Pan WH; Wang TY; Huang CJ
    J Surg Res; 2015 Jun; 196(2):325-31. PubMed ID: 25862489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sphingosine-1-phosphate and its analogue FTY720 diminish acute pulmonary injury in rats with acute necrotizing pancreatitis.
    Liu HB; Cui NQ; Wang Q; Li DH; Xue XP
    Pancreas; 2008 Apr; 36(3):e10-5. PubMed ID: 18362832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effects of sphingosine 1-phosphate in murine endotoxin-induced inflammatory lung injury.
    Peng X; Hassoun PM; Sammani S; McVerry BJ; Burne MJ; Rabb H; Pearse D; Tuder RM; Garcia JG
    Am J Respir Crit Care Med; 2004 Jun; 169(11):1245-51. PubMed ID: 15020292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Sphingosine-1 Phosphate receptor agonist FTY720 dose dependently affected endothelial integrity in vitro and aggravated ventilator-induced lung injury in mice.
    Müller HC; Hocke AC; Hellwig K; Gutbier B; Peters H; Schönrock SM; Tschernig T; Schmiedl A; Hippenstiel S; N'Guessan PD; Rosseau S; Suttorp N; Witzenrath M
    Pulm Pharmacol Ther; 2011 Aug; 24(4):377-85. PubMed ID: 21419858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of sphingosine 1-phosphate on morphological and functional responses in endothelia and venules after scalding injury.
    Liu X; Wu W; Li Q; Huang X; Chen B; Du J; Zhao K; Huang Q
    Burns; 2009 Dec; 35(8):1171-9. PubMed ID: 19520517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical treatment targeting sphingosine-1-phosphate and sphingosine lyase abrogates experimental allergic rhinitis in a murine model.
    Kleinjan A; van Nimwegen M; Leman K; Hoogsteden HC; Lambrecht BN
    Allergy; 2013 Feb; 68(2):204-12. PubMed ID: 23253209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
    Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
    Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The utility of pharmacokinetic-pharmacodynamic modeling in the discovery and optimization of selective S1P(1) agonists.
    Taylor S; Gray JR; Willis R; Deeks N; Haynes A; Campbell C; Gaskin P; Leavens K; Demont E; Dowell S; Cryan J; Morse M; Patel A; Garden H; Witherington J
    Xenobiotica; 2012 Jul; 42(7):671-86. PubMed ID: 22225501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FTY720 reduces extracellular matrix expansion associated with ischemia-reperfusion induced injury.
    Delbridge MS; Shrestha BM; Raftery AT; El Nahas AM; Haylor J
    Transplant Proc; 2007 Dec; 39(10):2992-6. PubMed ID: 18089307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary and vascular pharmacology of sphingosine 1-phosphate.
    Brinkmann V; Baumruker T
    Curr Opin Pharmacol; 2006 Jun; 6(3):244-50. PubMed ID: 16563863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FTY720 improves functional recovery after spinal cord injury by primarily nonimmunomodulatory mechanisms.
    Norimatsu Y; Ohmori T; Kimura A; Madoiwa S; Mimuro J; Seichi A; Yatomi Y; Hoshino Y; Sakata Y
    Am J Pathol; 2012 Apr; 180(4):1625-35. PubMed ID: 22417787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fingolimod therapy in multiple sclerosis--the issue of the pathomechanism].
    Tar L; Vécsei L
    Ideggyogy Sz; 2012 Mar; 65(3-4):83-100. PubMed ID: 23136726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The sphingosine-1-phosphate analogue FTY720 reduces atherosclerosis in apolipoprotein E-deficient mice.
    Keul P; Tölle M; Lucke S; von Wnuck Lipinski K; Heusch G; Schuchardt M; van der Giet M; Levkau B
    Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):607-13. PubMed ID: 17158351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antagonism of sphingosine-1-phosphate receptors by FTY720 inhibits angiogenesis and tumor vascularization.
    LaMontagne K; Littlewood-Evans A; Schnell C; O'Reilly T; Wyder L; Sanchez T; Probst B; Butler J; Wood A; Liau G; Billy E; Theuer A; Hla T; Wood J
    Cancer Res; 2006 Jan; 66(1):221-31. PubMed ID: 16397235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FTY720, sphingosine 1-phosphate receptor modulator, ameliorates experimental autoimmune encephalomyelitis by inhibition of T cell infiltration.
    Kataoka H; Sugahara K; Shimano K; Teshima K; Koyama M; Fukunari A; Chiba K
    Cell Mol Immunol; 2005 Dec; 2(6):439-48. PubMed ID: 16426494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FTY720, a synthetic sphingosine 1 phosphate analogue, inhibits development of atherosclerosis in low-density lipoprotein receptor-deficient mice.
    Nofer JR; Bot M; Brodde M; Taylor PJ; Salm P; Brinkmann V; van Berkel T; Assmann G; Biessen EA
    Circulation; 2007 Jan; 115(4):501-8. PubMed ID: 17242282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sphingosine-1-Phosphate Receptor-1 Agonist Sew2871 Causes Severe Cardiac Side Effects and Does Not Improve Microvascular Barrier Breakdown in Sepsis.
    Flemming S; Burkard N; Meir M; Schick MA; Germer CT; Schlegel N
    Shock; 2018 Jan; 49(1):71-81. PubMed ID: 28538086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of ischemia-reperfusion injury in the rat kidney by FTY720, a synthetic derivative of sphingosine.
    Delbridge MS; Shrestha BM; Raftery AT; El Nahas AM; Haylor JL
    Transplantation; 2007 Jul; 84(2):187-95. PubMed ID: 17667810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung tumor development in the presence of sphingosine 1-phosphate agonist FTY720.
    Salinas NR; Lopes CT; Palma PV; Oshima CT; Bueno V
    Pathol Oncol Res; 2009 Dec; 15(4):549-54. PubMed ID: 19214784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.